by Chester Tam | Jan 24, 2022 | Obesity Medicine
High Blood Pressure is also called hypertension. You and your physician should be concerned about your blood pressure being elevated because, over time, it puts you at risk for many serious health problems, including: Heart Disease Heart Attacks Stroke Heart Failure...
by swlc | Nov 6, 2021 | Obesity Medicine
Too often, patients blame themselves for gaining weight. They say, “it’s my fault. I just have no self-control. I know what to do, I just can’t do it” Many physicians cause more harm than good by advising patients to “eat less and exercise more.” Patients are left to...
by swlc | Nov 6, 2021 | Obesity Medicine
Patients with obesity are frequently advised to lose weight prior to total knee or total hip replacement. The reasons for this recommendation are numerous: Patients with obesity (BMI >30) are 1.7 times more likely to have complications after total joint replacement...
by Chester Tam | Aug 19, 2021 | Medical Aesthetics, Obesity Medicine, Pharmacology, Research
Diana Bone MSN, FNP-C There’s been a lot of buzz lately about Wegovy® (semaglutide) and Plenity® (Gelesis-100). Both medications are used to help with weight loss. But how are they the same and how are they different? What is Wegovy? Recently, the FDA approved a new...
by Chester Tam | Aug 15, 2021 | Obesity Medicine
Robert Ziltzer, MD, FACP, FAAP, FOMA There are many choices when it comes to anti-obesity medications. The recent release of Wegovy® (Semaglutide) has been very effective leading to 15% weight loss. Let’s look at why phentermine is still the most used weight loss...
by swlc | Jun 9, 2021 | News, Obesity Medicine
On June 4, 2021, the FDA approved Wegovy™ (Semaglutide) a weekly injection for the treatment of obesity. As a medical weight clinic, we are always skeptical about new treatments for obesity, and for good reason. Marketers flood the web with miracle cures for obesity...
